Hollister said late last week it is divesting a portion of its wound care business, including its Hydrofera Blue, Endoform, Triact and FastCast products.
The Libertyville, Ill.-based company’s Hydrofera and Endoform businesses are actively being transitioned to new owners who will continue to manufacture and deliver the products, Hollister said.
“For more than 95 years, our company’s mission has been to make life more rewarding and dignified for people who use our products and services. We remain dedicated to our mission, and to serving our customers, the patients who rely on our products, and our employees around the world,” pres & CEO V. Maliekel said in a press relese.
Hollister added that it is helping support the new owners to minimize supply disruptions and limit the impact on customers of the devices, and that it will name the new owners of the product lines soon.
Early rates for DeviceTalks Boston end August 15th.
Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.
View Full Agenda
Register today to save. Use code LASTCALL to save an additional 10%.